Contraindications to progestin-only oral contraceptive pills among reproductive-aged women
- 1 September 2012
- journal article
- Published by Elsevier in Contraception
- Vol. 86 (3) , 199-203
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD047816)
This publication has 18 references indexed in Scilit:
- Contraceptive failure in the United StatesContraception, 2011
- Contraindications to Combined Oral Contraceptives Among Over-the-Counter Compared With Prescription UsersObstetrics & Gynecology, 2011
- Clinic Versus Over-the-Counter Access to Oral Contraception: Choices Women Make Along the US–Mexico BorderAmerican Journal of Public Health, 2010
- Considerations for the use of progestin‐only contraceptivesJournal of the American Academy of Nurse Practitioners, 2010
- Accuracy of Self-Screening for Contraindications to Combined Oral Contraceptive UseObstetrics & Gynecology, 2008
- Contraindications to oral contraceptive use among women in the United States, 1999–2001Contraception, 2007
- Agreement between women's and providers' assessment of hormonal contraceptive risk factorsContraception, 2006
- Maintenance of ovulation inhibition with the 75-μg desogestrel-only contraceptive pill (Cerazette®) after scheduled 12-h delays in tablet intakeContraception, 2005
- Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptivesContraception, 1998
- A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 μg/day or levonorgestrel 30 μg/day: Collaborative Study Group on the Desogestrel-containing Progestogen-only PillThe European Journal of Contraception & Reproductive Health Care, 1998